TAIHUSNOW CO.,LTD.
838262
Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
CN Stock MarketDetailed Quotes
300003 Lepu Medical Technology
- 12.02
- -0.03-0.25%
Post Market Dec 16 15:00 CST
22.60BMarket Cap31.97P/E (TTM)
12.09High11.92Low163.00KlotVolume12.02Open12.05Pre Close195.62MTurnover1.01%Turnover Ratio17.97P/E (Static)1.88BShares16.4852wk High1.45P/B19.42BFloat Cap8.9352wk Low14.46Limit Up1.62BShs Float45.66Historical High9.64Limit Down1.41%Amplitude1.63Historical Low0.47Dividend TTM12.00Avg Price84.93KlotAsk3.94%Div YieldTTM100Lot Size73.41KlotBid
Lepu Medical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -23.55%4.79B | -21.33%3.38B | -21.14%1.92B | -24.78%7.98B | -19.36%6.26B | -19.35%4.3B | -4.39%2.44B | -0.47%10.61B | -10.11%7.76B | -18.20%5.33B |
| Operating revenue | -23.55%4.79B | -21.33%3.38B | -21.14%1.92B | -24.78%7.98B | -19.36%6.26B | -19.35%4.3B | -4.39%2.44B | -0.47%10.61B | -10.11%7.76B | -18.20%5.33B |
| Other operating revenue | ---- | -16.87%28.35M | ---- | 12.83%64.24M | ---- | 27.41%34.1M | ---- | 21.80%56.93M | ---- | -2.75%26.76M |
| Total operating cost | -17.90%3.88B | -19.53%2.59B | -23.59%1.34B | -19.83%6.35B | -14.73%4.73B | -14.75%3.21B | -4.99%1.75B | -3.42%7.93B | -6.90%5.54B | -12.12%3.77B |
| Operating cost | -18.50%1.78B | -20.01%1.21B | -20.98%636.46M | -28.37%2.85B | -25.37%2.18B | -25.30%1.51B | -12.95%805.47M | -4.17%3.98B | -9.51%2.93B | -16.75%2.02B |
| Operating tax surcharges | -11.10%58.83M | -2.76%44.49M | -2.59%24.35M | -17.58%96.81M | -17.59%66.17M | -17.26%45.75M | -7.82%24.99M | 3.24%117.47M | -14.64%80.3M | -28.16%55.3M |
| Operating expense | -18.42%973.68M | -19.19%649.47M | -24.15%334.35M | -20.11%1.62B | -4.48%1.19B | -2.34%803.75M | -6.32%440.81M | -3.58%2.03B | -7.38%1.25B | -14.13%822.98M |
| Administration expense | -15.64%476.25M | -16.79%314.23M | -26.18%142.93M | 9.85%815.83M | 5.98%564.54M | 3.43%377.65M | 9.83%193.62M | -0.76%742.67M | 0.14%532.71M | 3.42%365.12M |
| Financial expense | -20.46%34.72M | -60.17%14.25M | -98.40%869.85K | -8.26%84.93M | -47.07%43.65M | -45.84%35.78M | 86.06%54.43M | -46.10%92.58M | -41.41%82.47M | -34.44%66.06M |
| -Interest expense (Financial expense) | 2.96%128.2M | 0.22%87.17M | -2.90%42.21M | -9.60%170.65M | -21.10%124.51M | -13.03%86.97M | -2.18%43.47M | -17.38%188.78M | -8.81%157.8M | -12.27%100.01M |
| -Interest Income (Financial expense) | 5.07%-84.46M | 7.35%-58.11M | 13.90%-29.41M | -31.09%-115.34M | -40.32%-88.97M | -51.52%-62.72M | -123.53%-34.16M | -52.80%-87.99M | -33.18%-63.41M | -39.25%-41.39M |
| Research and development | -17.45%557.05M | -19.28%356.15M | -14.06%197.39M | -8.11%879.42M | 0.46%674.83M | 0.40%441.22M | 8.14%229.69M | 5.41%957.06M | 11.14%671.74M | 17.83%439.48M |
| Credit Impairment Loss | 4.58%-20.53M | 5.27%-16.92M | 923.50%3.63M | 12.86%-29.87M | 5.83%-21.52M | -70.46%-17.87M | 43.43%-440.48K | -14.62%-34.28M | 13.97%-22.85M | 44.50%-10.48M |
| Asset Impairment Loss | -216.27%-19.29M | -849.08%-18.4M | -137.40%-328.2K | -334.99%-165.09M | -153.05%-6.1M | 2.13%-1.94M | 1,224.97%877.62K | -301.70%-37.95M | 7.69%-2.41M | ---1.98M |
| Other net revenue | 925.53%6.03M | -82.67%4.57M | 101.89%23.54M | -30.63%-77.8M | 98.84%-730.38K | 183.18%26.35M | 149.19%11.66M | 80.63%-59.56M | 78.42%-62.84M | 50.56%-31.68M |
| Fair value change income | -378.78%-11.2M | -55.88%7.18M | -40.69%3.42M | -30.06%3.09M | 140.43%4.02M | 9,139.82%16.27M | 215.65%5.76M | -84.93%4.42M | 94.71%-9.94M | -110.06%-180K |
| Invest income | 71.38%-11.71M | 14.96%-19.59M | 80.07%-4.29M | 78.05%-16.53M | 35.43%-40.93M | 42.32%-23.04M | 19.04%-21.54M | 81.02%-75.33M | 50.97%-63.39M | 43.36%-39.94M |
| -Including: Investment income associates | -22.63%-54.47M | -114.73%-34.14M | 20.22%-15.81M | 73.18%-24.36M | 33.76%-44.41M | 63.47%-15.9M | 26.22%-19.82M | 40.34%-90.83M | 37.92%-67.05M | 41.23%-43.52M |
| Asset deal income | 930.80%12.37M | 845.53%11.85M | -131.97%-400.6K | -16,877.20%-4.07M | -602.19%-1.49M | 241.02%1.25M | 1,737.41%1.25M | -99.88%24.27K | -98.53%296.38K | 547.73%367.42K |
| Other revenue | -13.62%56.39M | -21.70%40.46M | -16.44%21.52M | 61.16%134.68M | 84.16%65.29M | 151.61%51.67M | 196.89%25.75M | 5.09%83.57M | 0.99%35.45M | -12.52%20.54M |
| Operating profit | -40.53%910.74M | -27.99%801.97M | -12.95%609.22M | -41.02%1.55B | -28.95%1.53B | -27.28%1.11B | 2.24%699.84M | 22.31%2.62B | -9.77%2.16B | -29.30%1.53B |
| Add:Non operating Income | -74.86%12.08M | -77.30%8.18M | -78.50%7.13M | 214.13%44.39M | 207.44%48.05M | 523.82%36.04M | 931.41%33.16M | -77.80%14.13M | -16.81%15.63M | -63.85%5.78M |
| Less:Non operating expense | 199.93%19.91M | 263.27%14.12M | 346.62%9.14M | 45.58%37.11M | -57.79%6.64M | -61.83%3.89M | -75.13%2.05M | -58.96%25.49M | -43.36%15.73M | -1.80%10.19M |
| Total profit | -42.60%902.91M | -30.53%796.03M | -16.93%607.21M | -40.48%1.55B | -27.02%1.57B | -24.96%1.15B | 7.57%730.96M | 21.70%2.61B | -9.43%2.16B | -29.69%1.53B |
| Less:Income tax cost | -29.53%119.56M | -28.29%106.02M | 1.61%114.45M | -28.32%262.15M | -46.86%169.66M | -35.77%147.83M | -4.04%112.64M | -0.00%365.73M | -12.94%319.28M | -35.39%230.15M |
| Net profit | -44.18%783.35M | -30.86%690.01M | -20.31%492.76M | -42.46%1.29B | -23.57%1.4B | -23.05%998.01M | 10.00%618.32M | 26.15%2.25B | -8.79%1.84B | -28.57%1.3B |
| Net profit from continuing operation | -44.18%783.35M | -30.86%690.01M | -20.31%492.76M | -42.46%1.29B | -23.57%1.4B | -23.05%998.01M | 10.00%618.32M | 26.15%2.25B | -8.79%1.84B | -28.57%1.3B |
| Less:Minority Profit | -138.91%-19.31M | -119.81%-7.23M | -49.10%10.89M | -19.22%34.15M | 91.20%49.63M | 26.39%36.52M | 27.84%21.39M | -30.80%42.28M | -71.75%25.96M | -67.87%28.9M |
| Net profit of parent company owners | -40.70%802.66M | -27.48%697.24M | -19.27%481.87M | -42.91%1.26B | -25.22%1.35B | -24.17%961.49M | 9.45%596.92M | 28.18%2.2B | -5.78%1.81B | -26.53%1.27B |
| Earning per share | ||||||||||
| Basic earning per share | -40.30%0.4339 | -27.06%0.3766 | -19.06%0.2594 | -44.74%0.6757 | -28.45%0.7268 | -27.46%0.5163 | 4.94%0.3205 | 27.43%1.2228 | -5.24%1.0158 | -26.10%0.7117 |
| Diluted earning per share | -40.21%0.4339 | -26.83%0.3766 | -18.63%0.2585 | -44.29%0.6757 | -27.80%0.7257 | -26.88%0.5147 | 4.85%0.3177 | 27.54%1.2129 | -4.66%1.0051 | -25.22%0.7039 |
| Other composite income | -114.98%-9.91M | -312.30%-115.07M | -122.62%-8.8M | 115.71%63.43M | 129.95%66.17M | 122.64%54.2M | 128.49%38.89M | -338.76%-403.72M | -359.63%-220.97M | -252.58%-239.45M |
| Other composite income of parent company owners | -90.66%7.49M | -248.21%-98.32M | -106.90%-2.88M | 122.43%86.64M | 137.28%80.16M | 128.55%66.34M | 133.26%41.77M | -339.94%-386.24M | -339.93%-215.01M | -247.30%-232.38M |
| Other composite income of minority owners | -24.41%-17.4M | -38.10%-16.76M | -105.63%-5.91M | -32.73%-23.21M | -134.61%-13.98M | -71.66%-12.13M | 73.63%-2.88M | -315.44%-17.49M | -32.37%-5.96M | -763.07%-7.07M |
| Total composite income | -47.36%773.44M | -45.36%574.93M | -26.36%483.96M | -26.41%1.36B | -9.02%1.47B | -0.50%1.05B | 54.41%657.21M | -5.50%1.84B | -23.02%1.62B | -46.39%1.06B |
| Total composite income of parent company owners | -43.49%810.14M | -41.73%598.92M | -25.01%478.99M | -26.01%1.34B | -10.11%1.43B | -0.76%1.03B | 52.14%638.69M | -3.34%1.82B | -20.67%1.6B | -45.02%1.04B |
| Total composite income of minority owners | -202.99%-36.71M | -198.38%-23.99M | -73.13%4.97M | -55.86%10.94M | 78.25%35.64M | 11.73%24.39M | 217.88%18.52M | -64.18%24.79M | -77.12%19.99M | -75.50%21.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
